Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
kaipharma.com

See what CB Insights has to offer

Competitors

39

Business Relationships

2

Service Providers

3

KAI Pharmaceuticals Competitors & Alternatives

39 Competitors

KAI Pharmaceuticals has 39 competitors. KAI Pharmaceuticals's competitors are Tetraphase Pharmaceuticals, Asteres, Vasopharm, Aegerion Pharmaceuticals, Eiger BioPharmaceuticals and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

7/28/2020

Acq - P2P

$98.5M

Massachusetts

4/29/2020

Loan

$8.8M

California

7/11/2019

Series H

$56.62M

Germany

5/21/2019

Asset Sale

$40.11M

Massachusetts

6/29/2017

Asset Sale

$21.56M

California

6/14/2017

IPO

$130.97M

New York

3/1/2017

Acq - P2P

$86.85M

North Carolina

2/9/2017

Merger

$29.34M

California

8/23/2016

Reverse Merger

California

4/5/2016

Series B

$43.79M

California

Latest Funding

7/28/2020

4/29/2020

7/11/2019

5/21/2019

6/29/2017

6/14/2017

3/1/2017

2/9/2017

8/23/2016

4/5/2016

Companies

Investment Stage

Acq - P2P

Loan

Series H

Asset Sale

Asset Sale

IPO

Acq - P2P

Merger

Reverse Merger

Series B

Total Funding

$98.5M

$8.8M

$56.62M

$40.11M

$21.56M

$130.97M

$86.85M

$29.34M

$43.79M

Mosaic

Location

Massachusetts

California

Germany

Massachusetts

California

New York

North Carolina

California

California

California

KAI Pharmaceuticals Service Providers

3 Service Providers

KAI Pharmaceuticals has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Series B

Counsel

General Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Series B

Subscribe to see more

Provider Type

Counsel

Subscribe to see more

Subscribe to see more

Service Type

General Counsel

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

KAI Pharmaceuticals Partners & Customers

2 Partners and customers

KAI Pharmaceuticals has 2 strategic partners and customers. KAI Pharmaceuticals recently partnered with Bristol-Myers Squibb on May 5, 2008.

Date

Type

Business Partner

Country

News Snippet

Sources

5/13/2008

Partner

Bristol-Myers Squibb

United States

Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance - Lumira First-in-Class Compound Designed to Improve Clinical Outcomes During Treatment of a Heart Attack.

Princeton , NJ , and South San Francisco , CA -- May 13 , 2008 -- Bristol-Myers Squibb and KAI Pharmaceuticals , Inc. , a privately held biotechnology company , today announced an exclusive agreement for the global development and commercialization of KAI-9803 , KAI Pharmaceuticals , Inc. 's proprietary , first-in-class inhibitor of the delta protein kinase C pathway .

1

1/9/2006

Partner

Daiichi Sankyo

Japan

Subscribe to see more

Subscribe to see more

10

Date

5/13/2008

1/9/2006

Type

Partner

Partner

Business Partner

Bristol-Myers Squibb

Daiichi Sankyo

Country

United States

Japan

News Snippet

Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance - Lumira First-in-Class Compound Designed to Improve Clinical Outcomes During Treatment of a Heart Attack.

Princeton , NJ , and South San Francisco , CA -- May 13 , 2008 -- Bristol-Myers Squibb and KAI Pharmaceuticals , Inc. , a privately held biotechnology company , today announced an exclusive agreement for the global development and commercialization of KAI-9803 , KAI Pharmaceuticals , Inc. 's proprietary , first-in-class inhibitor of the delta protein kinase C pathway .

Subscribe to see more

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.